Taíssa Maíra Thomaz Araújo

Taíssa Maíra Thomaz Araújo

Auto-generated profile, based on publicly available information

Taíssa Maíra Thomaz Araújo

Universidade Federal do Pará, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
André Salim KhayatAndré Salim Khayat
André Salim Khayat
PAPaulo Pimentel de Assumpção
Paulo Pimentel de Assumpção
BKBruna Claudia Meireles Khayat
Bruna Claudia Meireles Khayat
TATaíssa Maíra Thomaz Araújo
Taíssa Maíra Thomaz Araújo
JBJéssica Almeida Batista-Gomes
Jéssica Almeida Batista-Gomes
SSSidney Emmanuel Batista dos Santos
Sidney Emmanuel Batista dos Santos
The clinical condition COVID-19, caused by SARS-CoV-2, was declared a pandemic by the WHO in March 2020. Currently, there are more than 5 million cases worldwide, and the pandemic has increased exponentially in many countries, with different incidences and death rates among regions/ethnicities and, intriguingly, between sexes. In addition to the many factors that can influence these discrepancies, we suggest a biological aspect, the genetic variation at the viral S protein receptor in human cells, ACE2 (angiotensin I-converting enzyme 2), which may contribute to the worse clinical outcome in males and in some regions worldwide. We performed exomics analysis in native and admixed South American populations, and we also conducted in silico genomics databank investigations in populations from other continents. Interestingly, at least ten polymorphisms in coding, noncoding and regulatory sites were found that can shed light on this issue and offer a plausible biological explanation for these epidemiological differences. In conclusion, there are ACE2 polymorphisms that could influence epidemiological discrepancies observed among ancestry and, moreover, between sexes.

29 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
André Salim KhayatAndré Salim Khayat
André Salim Khayat
PAPaulo Assumpcao
Paulo Assumpcao
BKBruna Claudia Meireles Khayat
Bruna Claudia Meireles Khayat
TATaíssa Maíra Thomaz Araújo
Taíssa Maíra Thomaz Araújo
JBJéssica Almeida Batista-Gomes
Jéssica Almeida Batista-Gomes
SSSidney Santos
Sidney Santos
The clinical condition COVID-19, caused by SARS-CoV-2, was declared a pandemic by the WHO in March 2020. Currently, there are more than 5 million cases worldwide, and the pandemic has increased exponentially in many countries, with different incidences and death rates among regions/ethnicities and, intriguingly, between sexes. In addition to the many factors that can influence these discrepancies, we suggest a biological aspect, the genetic variation at the viral S protein receptor in human cells, ACE2 (angiotensin I-converting enzyme 2), which may contribute to the worse clinical outcome in males and in some regions worldwide. We performed exomics analysis in native and admixed South American populations, and we also conducted in silico genomics databank investigations in populations from other continents. Interestingly, at least ten polymorphisms in coding, noncoding and regulatory sites were found that can shed light on this issue and offer a plausible biological explanation for these epidemiological differences. In conclusion, ACE2 polymorphisms should influence epidemiological discrepancies observed among ancestry and, moreover, between sexes.

1 January 2026 in Genetics and Molecular Biology
Verified
Journal Article
Open access
TATaíssa Maíra Thomaz Araújo
Taíssa Maíra Thomaz Araújo
BRBianca de Fátima dos Reis Rodrigues
Bianca de Fátima dos Reis Rodrigues
JSJessica Manoelli Costa da Silva
Jessica Manoelli Costa da Silva
MRMyrth Soares Do Nascimento Remígio
Myrth Soares Do Nascimento Remígio
Fabiano MoreiraFabiano Moreira
Fabiano Moreira
PAPaulo Assumpcao
Paulo Assumpcao
Alanyl aminopeptidase (ANPEP) has been implicated in various cancers, but its specific role in gastric adenocarcinoma (GC) remains incompletely understood. This study analyzed ANPEP gene expression in gastric cancer (GC), peritumoral tissue (PTT), metaplasia (M), and normal tissue (N). Total RNA was extracted, libraries were prepared and sequenced on the Illumina NextSeq 500. Data were processed using the nf-core/rnaseq pipeline. Transcript quantifications were imported with tximport and normalized using DESeq2. Differential expression (|log₂FC| > 1; adj. p < 0.05) and Kruskal-Wallis tests identified key genes. ANPEP was significantly upregulated in GC, PTT, and M compared to normal tissue (p < 0.01), suggesting its involvement in early mucosal transformation and malignant progression. Heatmap and pathway enrichment analysis revealed upregulation of genes related to immune function and oxidative stress, indicating an immunosuppressive and apoptosis-resistant tumor microenvironment. Correlation analyses identified strong positive associations between ANPEP and genes involved in cytoskeletal remodeling, immune modulation, and metabolic regulation, suggesting that ANPEP supports both the invasive potential of tumor cells and the establishment of an immunosuppressive, therapy-resistant niche. These findings position ANPEP as a promising biomarker for early detection and a candidate for targeted therapies.

16 January 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
AOAna Carolina Favacho Miranda de Oliveira
Ana Carolina Favacho Miranda de Oliveira
AMAntonio Conde Modesto
Antonio Conde Modesto
Fabiano MoreiraFabiano Moreira
Fabiano Moreira
TATaíssa Maíra Thomaz Araújo
Taíssa Maíra Thomaz Araújo
MSMarcelli Geise de Oliveira Prata da Silva
Marcelli Geise de Oliveira Prata da Silva
André Salim KhayatAndré Salim Khayat
André Salim Khayat
Gastric cancer is a major public health problem, considered the fifth most frequently diagnosed cancer worldwide. Peritoneal metastasis is the main causes of mortality related to gastric cancer. The hypermethylation of tumor suppressors genes is a promising factor for the development of predictive biomarkers. In gastric tumors, reduced expression of CDH1 suppressor gene contributes to tumor invasion and triggering metastasis. We aim to evaluate the promoter region methylation profile of the CDH1 gene as a peritoneal metastasis indicator in patients with gastric cancer. CDH1 methylation profile were evaluate in 47 samples of peritoneal washes from patients with gastric cancer by bisulfite sequencing PCR (BSP). Thirty-three CpGs sites in the CDH1 promoter region were individually evaluated. Samples with ≥ 10% of methylated CpGs sites were considered hypermethylated. Statistical analysis was performed by Fisher's Exact test using R-Studio program (p≤0.05). Twenty-nine (62%) samples showed hypermethylation in the promoter region of CDH1, with preferential methylation at the CpGs sites located in the region 5' upstream from gene. Statistical analysis showed that CDH1 hypermethylation was significantly different in patients with advanced stages of tumor depth of invasion (p=0.03). Our results suggest that CDH1 gene methylation analysis is a useful tool in predicting tumor progression and invasiveness in gastric cancer patients and could have a major impact for the field of precision cancer medicine.